Please use this identifier to cite or link to this item:
Title: Novel glutamatergic agents for major depressive disorder and bipolar disorder
Authors: MACHADO-VIEIRA, RodrigoIBRAHIM, LobnaHENTER, Loline D.ZARATE JR., Carlos A.
Citation: PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, v.100, n.4, Special Issue, p.678-687, 2012
Abstract: Mood disorders such as major depressive disorder (MDD) and bipolar disorder (BPD) are common, chronic, recurrent mental illnesses that affect the lives and functioning of millions of individuals worldwide. Growing evidence suggests that the glutamatergic system is central to the neurobiology and treatment of these disorders. Here, we review data supporting the involvement of the glutamatergic system in the pathophysiology of mood disorders as well as the efficacy of glutamatergic agents as novel therapeutics.
Appears in Collections:Artigos e Materiais de Revistas Científicas - LIM/27

Files in This Item:
File Description SizeFormat 
  Restricted Access
publishedVersion (English)303.46 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.